A medic wearing protective face gloves holds an ampule with Russia's Sputnik V vaccine as Belarus launches its double blind randomized placebo-controlled study of the Russia's vaccine, at the City Polyclinic №28, in Minsk, Belarus. One hundred people will have the opportunity to get inoculated with the Sputnik V vaccine, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology.

01.10.2020#6345603

A medic wearing protective face gloves holds an ampule with Russia's Sputnik V vaccine as Belarus launches its double blind randomized placebo-controlled study of the Russia's vaccine, at the City Polyclinic №28, in Minsk, Belarus. One hundred people will have the opportunity to get inoculated with the Sputnik V vaccine, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology.

01.10.2020#6345602

A man wearing a face mask takes part in the double blind randomized placebo-controlled study of Russia's Sputnik V vaccine, at the City Polyclinic №28, in Minsk, Belarus. One hundred people will have the opportunity to get inoculated with the Sputnik V vaccine, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology.

01.10.2020#6345601

A man wearing a face mask takes part in the double blind randomized placebo-controlled study of Russia's Sputnik V vaccine, at the City Polyclinic №28, in Minsk, Belarus. One hundred people will have the opportunity to get inoculated with the Sputnik V vaccine, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology.

01.10.2020#6345600

A medic wearing protective face gloves holds an ampule with Russia's Sputnik V vaccine as Belarus launches its randomized placebo-controlled study of the Russia's vaccine, at the City Polyclinic №28, in Minsk, Belarus. One hundred people will have the opportunity to get inoculated with the Sputnik V vaccine, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology.

01.10.2020#6345595